Results 261 to 270 of about 98,662 (362)

Migraine-like headaches: a systematic review of secondary etiologies, clinical features and therapeutic patterns (1977-2024). [PDF]

open access: yesJ Headache Pain
Gama-Reyes EG   +8 more
europepmc   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza   +27 more
wiley   +1 more source

Building a national headache medicine research network: The BE WELL with Migraine Champion Providers Network™

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective Our objective was to develop and assess the effectiveness of a national network of clinicians referring adults with migraine for a remotely delivered clinical trial. Background A national practice‐based research network in Headache Medicine would facilitate referrals into clinical trials.
Rebecca Erwin Wells   +55 more
wiley   +1 more source

Effects of Gluten on Gut Microbiota in Patients with Gastrointestinal Disorders, Migraine, and Dermatitis [PDF]

open access: gold
Ismael San Mauro Martín   +7 more
openalex   +1 more source

Can atogepant be a preventive treatment for cluster headache?—Insights from a case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão   +3 more
wiley   +1 more source

Magnesium supplementation for migraine prophylaxis. [PDF]

open access: yesCochrane Database Syst Rev
Rodriguez JP   +4 more
europepmc   +1 more source

Migraine and patent foramen ovale: correlation, coexistence, dependence. A narrative review

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This review looked at what scientists know about the connection between migraine and a small heart opening called a patent foramen ovale (PFO). It showed that people with migraine, especially with aura, often have PFO, but it is not certain whether closing this heart opening helps prevent strokes in these patients.
Olga Grodzka   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy